Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date: May 7, 2020
Event: Filing of a Registration Statement on Form S-3 to register shares of common stock issuable upon the exercise of warrants acquired in private placements completed in March 2020.
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, or cash flow data. The only financial figure disclosed relates to potential future proceeds:
- Potential Proceeds: Up to approximately $5.4 million upon the exercise of the Warrants, if exercised for cash.
- Current Proceeds: The Company will not receive any proceeds from the resale of shares by selling stockholders under this registration statement.
Material Changes
The filing reports the administrative action of registering shares for resale. It does not report material changes to the Company's financial position, operations, or capital structure as of the filing date, other than the potential for future capital inflow if warrants are exercised.
Guidance, Outlook, and Risks
- Registration Status: The Form S-3 Registration Statement has not yet become effective.
- Sales Restriction: No securities may be sold, nor may offers to buy be accepted, prior to the time the Registration Statement becomes effective.
- Offering Status: This Form 8-K does not constitute an offer to sell or a solicitation of an offer to buy securities.
- Proceeds Clarification: The Company explicitly states it is not offering shares for sale under the prospectus and will not receive proceeds from the selling stockholders' sales.
Investor Verification Checklist
- Verify the effectiveness status of the Form S-3 Registration Statement filed on May 7, 2020.
- Confirm the terms of the warrants issued in March 2020, specifically the exercise price and expiration date, to assess the likelihood of the $5.4 million in potential proceeds.
- Review the prospectus included in the Registration Statement for details on the selling stockholders and the number of shares registered.
- Check for subsequent filings regarding the actual exercise of warrants or the effectiveness of the registration statement.